Advances in research on the clinical application of allogeneic platelet-rich plasma

doi:10.3877/cma.j.issn.1673-9450.2024.04.017

Abstract

Abstract:

Autologous platelet-rich plasma (au-PRP) is a platelet concentrate derived from autologous blood via centrifugation, which has been widely used in clinical practice owing to its pronounced tissue reparative and regenerative properties. However, its application is circumscribed by contraindications and relative contraindications, alongside potential attenuations in efficacy linked to factors such as age and basic diseases. Consequently, researchers have undertaken investigations into allogeneic platelet-rich plasma (al-PRP). This article comprehensively reviewed the feasibility and safety of al-PRP utilization, and the advantages, drawbacks and clinical applications of al-PRP.

Key words: Allogeneic platelet-rich plasma, Refractory wound, Motor system injuries

Qian Zhao, Yakun Li, Zhi Li. Advances in research on the clinical application of allogeneic platelet-rich plasma[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(04): 364-367.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2024.04.017

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2024/V19/I04/364

References 43

[1]	Akbarzadeh S, McKenzie MB, Rahman MM, et al. Allogeneic platelet-rich plasma: is it safe and effective for wound repair？[J]. Eur Surg Res, 2021，62(1)：1-9.
[2]	He M, Chen T, Lv Y, et al. The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: current perspectives and future challenges[J]. Front Bioeng Biotechnol，2022，10：993436.
[3]	李娇，李晓丰，李剑平．异体浓缩血小板治疗慢性难愈性创面的影响因素[J].中国组织工程研究，2024，28(13)：2114-2119.
[4]	Crowe JH, Tablin F, Wolkers WF, et al. Stabilization of membranes in human platelets freeze-dried with trehalose[J]. Chem Phys Lipids, 2003，122(1-2)：41-52.
[5]	杨振宇，李正发，付凌梅，等．深低温冷冻保存血小板的最佳温度及时限[J].中国组织工程研究，2018，22(33)：5368-5372.
[6]	Freitas NPP, Maior MMMS, Silva BAP, et al. In-vitro production and pre-validation of lyophilized canine platelet-rich plasma for therapeutic use[J]. Pesquisa Veterinária Brasileira，2021，41：e06999.
[7]	何涛，耿鸿武，付涌水．输血服务蓝皮书：中国输血行业发展报告(2019)[M]. 武汉：社会科学文献出版社，2019：94-108.
[8]	Xian LJ, Chowdhury SR, Bin Saim A, et al.Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing[J]. Cytotherapy，2015，17(3)：293-300.
[9]	Cavallo C, Roffi A, Grigolo B, et al.Platelet-rich plasma：the choice of activation method affects the release of bioactive molecules[J]. Biomed Res Int，2016，2016：6591717.
[10]	Sumner SM, Naskou MC, Thoresen M, et al. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors[J]. Transfusion，2017，57(7)：1755-1762.
[11]	Du L, Miao Y, Li X, et al. A novel and convenient method for the preparation and activation of PRP without any additives: temperature controlled PRP[J]. Biomed Res Int，2018，2018：1761865.
[12]	Stukel JR，Schara K，Bedina-Zavec A, et al. Effect of shear stress in the flow through the sampling needle on concentration of nanovesicles isolated from blood[J]. Eur J Pharm Sci，2017，98：17-29.
[13]	Arnoczky SP, Sheibani-Rad S. The basic science of platelet-rich plasma (PRP): what clinicians need to know[J]. Sports Med Arthrosc, 2013, 21(4)：180-185.
[14]	单桂秋，施琳颖，李艳辉，等．自体富血小板血浆制备技术专家共识[J].中国输血杂志，2021，34(7)：677-683.
[15]	Rozman P． Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation[J]. Transpl Immunol，2002, 10(2-3)：165-181.
[16]	Marino J, Paster J, Benichou G. Allorecognition by T lymphocytes and allograft rejection[J]. Front Immunol，2016，7：582.
[17]	姚丹，赵帆，郝岱峰，等．异体富血小板血浆免疫原性的小型猪动物实验研究[J].中华损伤与修复杂志(电子版)，2018，13(6)：439-443.
[18]	Zhang ZY, Huang AW, Fan JJ，et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J]. Cell Transplant，2013，22(1)：175-187.
[19]	Abouelnasr K, Hamed M, Lashen S. Enhancement of abdominal wall defect repair using allogenic platelet-rich plasma with commercial polyester/cotton fabric (Damour) in a canine model[J]. J Vet Med Sci，2017，79(7)：1301-1309.
[20]	Jeong SH, Han SK, Kim WK. Treatment of diabetic foot ulcers using a blood bank concentrate[J]. Plast Reconstr Surg，2010，125(3)：944-952.
[21]	Raeissadat SA, Rayegani SM, Ahangar AG，et al. Efficacy of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single-blinded randomized clinical trial[J]. Clin Med Insights Arthritis Musculoskelet Disord，2017，10：1179544117733452.
[22]	Etulain J． Platelets in wound healing and regenerative medicine[J]. Platelets，2018，29(6)：556-568.
[23]	田举．年龄、疾病对富血小板血浆活性成分影响及其制备的优化[D].南方医科大学，2019.
[24]	Tyndall WA, Beam HA, Zarro C, et al.Decreased platelet derived growth factor expression during fracture healing in diabetic animals[J].Clin Orthop Relat Res，2003(408)：319-330.
[25]	Barrionuevo DV, Laposy CB, Abegão KG，et al.Comparison of experimentally-induced wounds in rabbits treated with different sources of platelet-rich plasma[J]. Lab Anim，2015，49(3)：209-214.
[26]	Saputro ID, Rizaliyana S, Noverta DA. The effect of allogenic freeze-dried platelet-rich plasma in increasing the number of fibroblasts and neovascularization in wound healing[J]. Ann Med Surg (Lond)，2022，73：103217.
[27]	Kaufman RM, Djulbegovic B, Gernsheimer T，et al. Platelet transfusion: a clinical practice guideline from the AABB[J]. Ann Intern Med，2015，162(3)：205-213.
[28]	Garraud O, Hamzeh-Cognasse H, Chalayer E，et al. Platelet transfusion in adults: an update[J]. Transfus Clin Biol，2023，30(1)：147-165.
[29]	王鹏，尹斌，苏映军，等. 长链非编码RNA介导慢性难愈性创面愈合的机制研究进展[J].中华烧伤杂志，2020，36(8)：758-761.
[30]	He M, Guo X, Li T, et al. Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers[J]. Cell Transplant，2020，29：963689720931428.
[31]	刘鸿雁，黄文炼，李竺憬，等．同种异体富血小板血浆凝胶治疗慢性难愈性创面的疗效分析[J].中国美容整形外科杂志，2021，32(12)：741-744，755.
[32]	Liao X, Liang JX, Li SH, et al. Allogeneic platelet-rich plasma therapy as an effective and safe adjuvant method for chronic wounds[J]. J Surg Res，2020，246：284-291.
[33]	周婉，吴磊，周济宏，等．同种异体富血小板血浆治疗继发带状疱疹创面的探讨—附1例报道[J].中国输血杂志，2023，36(5)：436-439.
[34]	黄红梅，方勇飞，蒋天伦，等．同种异体富血小板血浆治疗白塞氏病难治性外阴溃疡1例[J].中国输血杂志，2018，31(9)：1038-1040.
[35]	Marck RE, van der Bijl I, Korsten H, et al. Activation, function and content of platelets in burn patients[J]. Platelets，2019，30(3)：396-402.
[36]	陈凤超，陈民才，颜彤彤，等．同种异体富血小板血浆对创面胶原合成的作用及其机制研究[J].中华外科杂志，2017，55(4)：303-307.
[37]	巩蜜蜜，汪海宁，吴磊，等．同种异体富血小板血浆用于慢性难愈性创面的临床研究[J].临床输血与检验，2023，25(3)：368-374.
[38]	赵露婷，方其林，唐海燕，等．自体、同种异体纯化富血小板血浆治疗兔膝骨关节炎的差异[J].中国组织工程研究，2021，25(26)：4123-4129.
[39]	Vinod E, Vinod Francis D, Manickam Amirtham S，et al. Allogeneic platelet rich plasma serves as a scaffold for articular cartilage derived chondroprogenitors[J].Tissue Cell，2019，56：107-113.
[40]	Kanwat H, Singh DM, Kumar CD，et al. The effect of intra-articular allogenic platelet rich plasma in Dunkin-Hartley guinea pig model of knee osteoarthritis[J]. Muscles Ligaments Tendons J，2018，7(3)：426-434.
[41]	El-Gohary R, Diab A, El-Gendy H，et al.Using intra-articular allogenic lyophilized growth factors in primary knee osteoarthritis: a randomized pilot study[J].Regen Med，2021，16(2)：113-115.
[42]	Kandil MI, Tabl EA, Elhammady AS. Prospective randomized evaluation of local injection of allogeneic growth factors in plantar fasciitis[J]. Foot Ankle Int，2020，41(11)：1335-1341.
[43]	Jo CH, Lee SY, Yoon KS，et al. Allogenic pure platelet-rich plasma therapy for rotator cuff disease: a bench and bed study[J]. Am J Sports Med，2018，46(13)：3142-3154.

Please choose a citation manager

Content to export